CGEM vs JNJ: Which Stock is Better?
Side-by-side comparison of Cullinan Oncology LLC and Johnson & Johnson in 2026
CGEM
Cullinan Oncology LLC
—
JNJ
Johnson & Johnson
$263.04
Key Metrics Comparison
| Metric | CGEM | JNJ | Winner |
|---|---|---|---|
| Market Cap | $830.30M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CGEM
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGEM or JNJ a better investment?
Comparing CGEM and JNJ: Cullinan Oncology LLC has a market cap of $830.30M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGEM and JNJ?
CGEM (Cullinan Oncology LLC) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGEM or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGEM or JNJ?
Both CGEM and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CGEM or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CGEM or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $830.30M for CGEM.
Should I buy CGEM or JNJ in 2026?
Both CGEM and JNJ have investment merit. CGEM trades at $N/A while JNJ trades at $263.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGEM and JNJ stock?
Key differences: Market Cap ($830.30M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CGEM or JNJ in 2026?
The choice between CGEM and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CGEM and JNJ?
CGEM (Cullinan Oncology LLC) has a market cap of $830.30M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.